Biohybrid cochlear implants in human neurosensory restoration

Table 1 Content of mesenchymal and hematopoietic stem cells in human bone marrow-derived mononuclear cell fraction

Conjugated antibody	Catalog number/Company	IVD/ASR/RUO	Fluorochrome	Clone
CD3-ECD	A07748/Beckman Coulter	IVD	ECD	UCHT1
CD14-PB	PN B00846/Beckman Coulter	ASR	PB	RMO52
CD34-PE	A07776/Beckman Coulter	IVD	PE	581
CD45-KO	IM3548/Beckman Coulter	IVD	PC7	J33
CD73-FITC	561254/BD Pharmingen™	RUO	FITC	AD2
CD90-FITC	PN IM1839U/Beckman Coulter	ASR	FITC	F15-42-1-5
CD105-APC	562408/BD Pharming™	RUO	APC	266
CD166-PE	PN A22361/Beckman Coulter	ASR	PE	3A6
HLA-DR-PB	PN A74781/Beckman Coulter	ASR	PB	Immu-357

Process performance was estimated by evaluations of the CD45^– and CD45⁺ cell recovery (%), and viability (%) of collected samples from two runs after bone marrow depletion. Individual values are represented from both processes including the percentage of total CD45⁺ and CD45^– cells, and the characterisations of viable progenitor cells with positive and negative discrimination markers among viable CD45^– cells. RUO research use only, IVD in vitro diagnostic, ASR analyte specific reagent, ECD electron coupled dye, PB pacific blue, PE phycoerythrin, PC7 phycoerythrin cyanin 7, FITC fluorescein isothiocyanate, APC allophycocyanin

ISSN: 1757-6512